Delivery Order SPE2DB24D1205-SPE2DB25FCYMX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Livalo 1 mg tablets (90-count packages) with a ceiling value of $4,675.27. This competitive award, executed as a firm fixed-price delivery order with no set-aside designation, represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's Corporate Office location...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,336.06 for 90 tablets of Livalo 2 mg on June 16, 2025, with an ultimate completion date of June 17, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $22,629.65 to AmerisourceBergen Drug Corp for the supply of Livalo 1 mg tablets (90-count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The delivery order is issued as a child contract under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,953.53 to AmerisourceBergen Drug Corp for the supply of Livalo 4 mg tablets (90-count units), with an ultimate completion date of August 13, 2025. This is a firm fixed-price delivery order under a non-set-aside competitive procurement. The awardee, AmerisourceBergen Drug Corp, is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and will fulfill this order from its corporate office location in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Livalo 2 mg tablets (90-count) with a ceiling value of $1,119.63. This firm fixed-price delivery order was competitively awarded without set-aside designation and has an ultimate completion date of July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LIVALO 2 MG TABLET 90S. The contract has a ceiling value of $1,273.59 and runs through August 6, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,624.90, is for the delivery of 90 tablets of the drug Livalo 2 mg. It is a firm-fixed price delivery order contract with a completion date of June 7, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of 4566357429 LIVALO 2 MG TABLET 90S. The contract has a firm-fixed-price delivery order valued at $11,875.13 with a completion date of November 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026,...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for $2,720.25. The order is for 90 tablets of the generic cholesterol medication Livalo 1 mg, to be delivered by December 6, 2023 to DLA's facility in Conshohocken, Pennsylvania. As a prime contractor supporting DLA Troop Support Medical, Amerisourcebergen will supply pharmaceutical products and medical supplies for military treatment programs. No set-aside...
- The Defense Logistics Agency awarded a $5,342 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 90 tablets of the pharmaceutical LIVALO 4 MG. As the prime contractor, Amerisourcebergen will deliver the specified pharmaceutical products to a location in Conshohocken, Pennsylvania by August 10, 2023 under the terms of the contract. No additional details were provided regarding major subcontractors or the use of any set aside designations. The Defense Logistics Agency...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCYMXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,835.51 to AmerisourceBergen Drug Corp for 90 tablets of Livalo 2 mg, a pharmaceutical product used to manage cholesterol levels. The award was issued on July 14, 2025, with an ultimate completion date of July 15, 2025, and was competitively awarded without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. This prime contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's federal procurement portfolio demonstrates consistent capability to fulfill medical supply requirements across multiple therapeutic domains through firm fixed-price delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/14/25 |